OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial introduction	251
Giant cell arteritis: update on pathogenesis and clinical implications	67
Current approach to muscle imaging in myositis	63
Epidemiology and outcomes of rheumatoid arthritis	55
Current views on lupus in children	52
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	51
Urticarial vasculitis	51
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	48
Selective immunoglobulin E deficiency: an overlooked hypogammaglobulinemia and its association with rheumatoid arthritis	39
Editorial introductions	36
What's next in psoriatic arthritis therapy? A look at the pipeline	36
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	35
Osteoporosis epidemiology using international cohorts	35
Axial spondyloarthritis guidelines – aiming for maximum impact	30
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden	27
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	25
Rheumatoid arthritis – the challenge of heterogeneity	24
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype	22
Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care	22
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	21
The gut microbiota in spondyloarthritis: an update	20
Editorial introductions	20
Updates on translational and clinical research in systemic sclerosis	20
Editorial introductions	19
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	19

Editorial introductions	18
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	18
Editorial introduction	18
Pathogenesis of skin damage in lupus: recent advances and future directions	17
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	16
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	16
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	16
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	15
Defining and managing flares in axial spondyloarthritis	15
Rheumatoid arthritis contributes to comorbidity burden through systemic inflammation and autoimmunity: examples of atherosclerotic cardiovascular disease, interstitial lung disease, and depression	15
Health inequities in the rheumatic diseases of childhood	14
How common is vasculitis: what do population-based data tell us?	14
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	14
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	14
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	14
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	14
Epidemiology of myositis	14
Editorial introductions	13
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	13
New developments related to lung complications in pediatric rheumatic disease	13
Investigating gout flares: beyond a definition	12
Biomarker discovery in psoriatic disease	12
Advances in the diagnosis and treatment of Sjögren disease	12
Diagnosis and management of primary heart involvement in systemic sclerosis	12
Environmental and occupational contributors to autoimmune, inflammatory, and musculoskeletal rheumatic disease: a review of emerging evidence and clinical implications	12
Editorial introduction	12
AI am the future: artificial intelligence in pediatric rheumatology	12
Epidemiology of osteoarthritis: literature update 2022–2023	11
Heart involvement in systemic sclerosis: emerging concepts	11
Vasculitis and the NLRP3 inflammasome	11
Management of postinfectious inflammatory arthritis	11
Exploring challenges in the management and treatment of inclusion body myositis	11
Eosinophilic granulomatosis with polyangiitis: recent therapeutic advances	11
Animal models in systemic sclerosis: an update	10
Update on streptococcal-associated rheumatic disease	10
Emerging biologic therapies for systemic lupus erythematosus	10
Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment	10
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	10
The contribution of endothelial cells to tissue fibrosis	10
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI	10
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications	10
Current management of giant cell arteritis and its complications	10